nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cardiovascular Risk Factors in Hypertension: Rationale and Design of Studies to Investigate the Effects of Controlled-Release Carvedilol on Regression of Left Ventricular Hypertrophy and Lipid Profile
|
Bakris, George L. |
|
2006 |
98 |
7S1 |
p. 46-52 7 p. |
artikel |
2 |
COMPARE: Comparison of the Effects of Carvedilol CR and Carvedilol IR on Left Ventricular Ejection Fraction in Patients with Heart Failure
|
Greenberg, Barry H. |
|
2006 |
98 |
7S1 |
p. 53-59 7 p. |
artikel |
3 |
Controlled-Release Carvedilol: A Concluding Perspective
|
Packer, Milton |
|
2006 |
98 |
7S1 |
p. 67-69 3 p. |
artikel |
4 |
Controlled-Release Carvedilol in the Treatment of Essential Hypertension
|
Weber, Michael A. |
|
2006 |
98 |
7S1 |
p. 32-38 7 p. |
artikel |
5 |
Development of a Pharmacokinetic/Pharmacodynamic Model for Carvedilol to Predict β1-Blockade in Patients with Congestive Heart Failure
|
Tenero, David M. |
|
2006 |
98 |
7S1 |
p. 27-31 5 p. |
artikel |
6 |
Introduction
|
Sica, Domenic A. |
|
2006 |
98 |
7S1 |
p. 1-4 4 p. |
artikel |
7 |
Pharmacokinetic and Pharmacodynamic Comparison of Controlled-Release Carvedilol and Immediate-Release Carvedilol at Steady State in Patients with Hypertension
|
Henderson, Linda S. |
|
2006 |
98 |
7S1 |
p. 17-26 10 p. |
artikel |
8 |
Pharmacokinetic Profile of Controlled-Release Carvedilol in Patients with Left Ventricular Dysfunction Associated with Chronic Heart Failure or After Myocardial Infarction
|
Packer, Milton |
|
2006 |
98 |
7S1 |
p. 39-45 7 p. |
artikel |
9 |
Pharmacokinetic Properties of a New Controlled-Release Formulation of Carvedilol
|
Tenero, David M. |
|
2006 |
98 |
7S1 |
p. 5-16 12 p. |
artikel |
10 |
Rationale and Design of CASPER: Compliance and Quality of Life Study Comparing Once-Daily Carvedilol CR and Twice-Daily Carvedilol IR in Patients with Heart Failure
|
Hauptman, Paul J. |
|
2006 |
98 |
7S1 |
p. 60-66 7 p. |
artikel |